s psychedelic-assisted therapy gains mainstream acceptance, the role of social workers, who provide a significant portion of mental health services in the United States, will become increasingly important in this emerging field, says an expert on mental health in the Brown School at Washington University in St. Louis.
Psychedelics such as psilocybin, MDMA and ketamine are showing promise in treating mental health issues such as post-traumatic stress disorder, addiction and depression, said Tonya Edmond, PhD, a professor. “I believe all of these medicines will be legally available in the near future, and social workers will be essential to their successful implementation, particularly in underserved communities,” she said.
“Social workers are deeply embedded throughout the mental health infrastructure across this country,” Edmond said. “We’re working in low-resourced organizations and communities. We have the opportunity to expand the reach of who has access to these kinds of therapeutic interventions.”
Currently, access to psychedelic-assisted therapy is limited, primarily available through clinical trials or underground markets. Edmond envisions a future where social work education includes training in these therapies, preparing students for potential roles as therapists.
At the Brown School, nearly half of the students are focused on clinical work with a concentration in mental health, making it practical to integrate psychedelic-assisted therapy training into the curriculum.